Home›Search›Nanomedicine: Nanotechnology, Biology, and Medicine

Nanomedicine: Nanotechnology, Biology, and Medicine

Elsevier Inc. · United States · Est. 1970

ISSN1549-9634eISSN1549-9642

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (3 more)+18

Total96

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 25% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.845

H-Indexi

171

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.678

Total Worksi

4,070

Total Citationsi

178,206

2yr Mean Citednessi

1.90

Open Impact Factor alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Nanomedicine: Nanotechnology, Biology, and Medicine aims to promote the interdisciplinary field of nanomedicine. The journal presents novel and significant research in this emerging field.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published1970

FrequencyQuarterly

StatusActive (last: 2026)

Total Publications4,070

Publisher OrgElsevier BV

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Elsevier Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1549-9634 / 1549-9642

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

221

8.6k

2019

181

4.9k

2020

156

3.4k

2021

131

2.1k

2022

2023

319

2024

147

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmaceutical ScienceQ1

BioengineeringQ2

Biomedical EngineeringQ2

Materials Science (miscellaneous)Q2

Medicine (miscellaneous)Q2

Molecular MedicineQ2

Nanoscience and NanotechnologyQ2

Subject Classification

Web of Science Categories

Medicine, Research & ExperimentalNanoscience & Nanotechnology

Scopus Categories

BioengineeringBiomedical EngineeringNanoscience and NanotechnologyPharmaceutical ScienceMaterials Science (miscellaneous)Medicine (miscellaneous)Molecular Medicine

Research Topics (OpenAlex)

Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryAdvanced biosensing and bioanalysis techniquesGraphene and Nanomaterials ApplicationsNanoparticles: synthesis and applicationsAdvanced Drug Delivery SystemsImmunotherapy and Immune ResponsesDiverse Scientific and Economic StudiesDendrimers and Hyperbranched Polymers

Frequently asked questions about Nanomedicine: Nanotechnology, Biology, and Medicine

Is Nanomedicine: Nanotechnology, Biology, and Medicine a predatory journal?

PubScope has no integrity flags on record for Nanomedicine: Nanotechnology, Biology, and Medicine: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Nanomedicine: Nanotechnology, Biology, and Medicine?

Nanomedicine: Nanotechnology, Biology, and Medicine is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.90.

Is Nanomedicine: Nanotechnology, Biology, and Medicine indexed in Scopus and Web of Science?

Nanomedicine: Nanotechnology, Biology, and Medicine is indexed in Web of Science, Scopus.